Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer

PaperCitations, authors & open-access status

A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 246 citations, 2012 year and hybrid oa status.

246
Citations
2012
Year
hybrid
OA Status

Related on ScholarIQ

Peter Strang
Author
European Journal of Cancer
Journal
Prostate Cancer Treatment and Research
Topic
Prostate Cancer Treatment and Research
Topic
Radiopharmaceutical Chemistry and Applications
Topic
Bone health and treatments
Topic
470M+ articles · free account